S. 139 · 114th Congress
Ensuring Access to Clinical Trials Act of 2015
- Stage
- Signed by the president
- Sponsor
- Ron Wyden
- Introduced
- 2015-01-08
- Latest action
- 2015-10-07 · Signed by President.
Summary
This measure has not been amended since it was introduced. The expanded summary of the Senate-passed version is repeated here.) Ensuring Access to Clinical Trials Act of 2015
(Sec. 2) This bill amends the Improving Access to Clinical Trials Act of 2009 to repeal the sunset of, and so extend indefinitely, the exclusion from resources under titles XVI (Supplemental Security Income) and XIX (Medicaid) of the Social Security Act, for eligibility purposes, of compensation in the amount of the first $2,000 per year received by individuals who participate in clinical trials for rare diseases or conditions.